Lam Research Co. (NASDAQ:LRCX) Stock Holdings Lifted by Bradley Foster & Sargent Inc. CT

Bradley Foster & Sargent Inc. CT lifted its position in Lam Research Co. (NASDAQ:LRCX) by 783.9% in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 5,551 shares of the semiconductor company’s stock after acquiring an additional 4,923 shares during the quarter. Bradley Foster & Sargent Inc. CT’s holdings in Lam Research were worth $401,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Physicians Financial Services Inc. purchased a new stake in shares of Lam Research in the fourth quarter valued at $508,000. Cassaday & Co Wealth Management LLC grew its holdings in shares of Lam Research by 900.0% during the fourth quarter. Cassaday & Co Wealth Management LLC now owns 7,660 shares of the semiconductor company’s stock valued at $553,000 after buying an additional 6,894 shares in the last quarter. Compass Capital Corp MA ADV acquired a new position in Lam Research during the fourth quarter valued at $1,703,000. Legacy Capital Group California Inc. lifted its stake in Lam Research by 1,380.9% in the 4th quarter. Legacy Capital Group California Inc. now owns 22,155 shares of the semiconductor company’s stock worth $1,600,000 after acquiring an additional 20,659 shares in the last quarter. Finally, Bray Capital Advisors boosted its position in Lam Research by 902.7% during the 4th quarter. Bray Capital Advisors now owns 26,751 shares of the semiconductor company’s stock worth $1,932,000 after acquiring an additional 24,083 shares during the period. Institutional investors and hedge funds own 84.61% of the company’s stock.

Insider Activity

In other news, SVP Seshasayee Varadarajan sold 110,080 shares of the company’s stock in a transaction dated Thursday, February 20th. The shares were sold at an average price of $90.00, for a total transaction of $9,907,200.00. Following the completion of the transaction, the senior vice president now owns 179,084 shares of the company’s stock, valued at approximately $16,117,560. This represents a 38.07 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. 0.29% of the stock is owned by company insiders.

Lam Research Stock Performance

NASDAQ:LRCX opened at $86.02 on Friday. The firm has a market capitalization of $110.42 billion, a PE ratio of 26.13, a PEG ratio of 1.47 and a beta of 1.46. The company has a current ratio of 2.54, a quick ratio of 1.73 and a debt-to-equity ratio of 0.51. Lam Research Co. has a 1 year low of $68.87 and a 1 year high of $113.00. The firm’s fifty day simple moving average is $78.46 and its 200 day simple moving average is $78.04.

Lam Research (NASDAQ:LRCX) last posted its quarterly earnings data on Wednesday, January 29th. The semiconductor company reported $0.91 EPS for the quarter, topping analysts’ consensus estimates of $0.87 by $0.04. Lam Research had a return on equity of 51.86% and a net margin of 26.49%. On average, sell-side analysts anticipate that Lam Research Co. will post 3.71 EPS for the current year.

Lam Research Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, April 9th. Stockholders of record on Wednesday, March 5th will be issued a dividend of $0.23 per share. The ex-dividend date is Wednesday, March 5th. This represents a $0.92 dividend on an annualized basis and a dividend yield of 1.07%. Lam Research’s dividend payout ratio (DPR) is presently 27.96%.

Analysts Set New Price Targets

A number of analysts have recently issued reports on LRCX shares. The Goldman Sachs Group reduced their price target on shares of Lam Research from $96.00 to $85.00 and set a “buy” rating for the company in a research report on Friday, January 10th. Morgan Stanley increased their target price on shares of Lam Research from $76.00 to $78.00 and gave the stock an “equal weight” rating in a research report on Thursday, December 5th. Mizuho boosted their price target on shares of Lam Research from $87.00 to $100.00 and gave the company an “outperform” rating in a report on Thursday. Barclays cut their price objective on Lam Research from $90.00 to $75.00 and set an “equal weight” rating for the company in a report on Friday, January 17th. Finally, Wells Fargo & Company boosted their target price on Lam Research from $82.00 to $85.00 and gave the company an “equal weight” rating in a research note on Thursday, January 30th. Six investment analysts have rated the stock with a hold rating and seventeen have assigned a buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $98.22.

About Lam Research

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.